NDC 51079-109-01 - Bupropion Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51079-109
- Requested NDC
- 51079-109-01
- Package NDCs from labels
- 51079-109-01, 51079-109-03
- Manufacturer
- Mylan Institutional Inc.
- Effective date
- 2018-11-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Bupropion Hydrochloride - Mylan Institutional Inc. | Mylan Institutional Inc. | 2018-11-20 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51079-109-01 | EA - Each | 51079-109 | b9018094-3c24-499d-8608-026edf7d080c | 1 | 2012-07-24 |
| 51079-109-03 | EA - Each | 51079-109 | 78ebe57d-abdc-48f5-a798-f59fcbf224e8 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Eyewash Station Additive Concentrate | CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL | Encon Safety Products, Inc. | b5a62567-c9f1-0492-e053-2a95a90ab247 | 2026-11-05 | Warnings | 6DC9Q167V3 |
| BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | NCS HealthCare of KY, LLC dba Vangard Labs | 4fbe64aa-f8f4-45fa-88ae-e844997703ae | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| Mannitol | MANNITOL | Henry Schein, Inc. | e2444db1-9dfe-451f-a33c-9b00786464d2 | 2026-11-02 | Warnings, Adverse reactions | 3OWL53L36A |
| Bupropion Hydrochloride SR | BUPROPION HYDROCHLORIDE | Epic Pharma, LLC | 669be59d-3d37-46f8-9dc0-8ef7303be5db | 2026-10-29 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| bupropion hydrochloride | BUPROPION HYDROCHLORIDE | REMEDYREPACK INC. | d087222e-c5e9-4c48-b27f-e2e2944379c8 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| Clear Eyes Triple Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | Prestige Brands Holdings, Inc. | 1269a1a6-843d-4d08-bb3c-c1f3d2e7080d | 2026-10-23 | Warnings | 532B59J990 FZ989GH94E |
| Bupropion Hydrochloride SR | BUPROPION HYDROCHLORIDE | REMEDYREPACK INC. | b47c5515-a438-40bc-b8ad-26a6cf9676b7 | 2026-10-19 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| Rohto Max Strength | NAPHAZOLINE HYDROCHLORIDE, POLYSORBATE 80 | The Mentholatum Company | e4b49550-1ca3-4bd7-854d-409b53fa5e26 | 2026-10-16 | Warnings | 6OZP39ZG8H |
| bupropion hydrochloride SR | BUPROPION HYDROCHLORIDE | QPharma Inc | 5d6c996e-8965-921c-e063-6394a90abb4e | 2026-10-15 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| bupropion hydrochloride | BUPROPION HYDROCHLORIDE | REMEDYREPACK INC. | 136f29fa-a859-4efb-8365-1382716d6f8f | 2026-10-15 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| Bupropion Hydrochloride SR | BUPROPION HYDROCHLORIDE | Dr. Reddys Laboratories Inc. | ad784c8e-7201-4336-a310-616e3e979ca4 | 2026-10-14 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| Artificial Tears | GLYCERIN | Preferred Pharmaceuticals Inc. | dd646c72-8f47-43c6-a734-db0dcc8cd4d1 | 2026-10-14 | Warnings | 3NXW29V3WO |
| Bupropion Hydrochloride SR | BUPROPION HYDROCHLORIDE | ScieGen Pharmaceuticals, Inc. | 092da413-ec60-4577-ac57-51e3e42d55c9 | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | Granules Pharmaceuticals Inc. | 61e9cbe3-8211-42f3-b68f-581f56651919 | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| Bupropion hydrochloride | BUPROPION HYDROCHLORIDE | NuCare Pharmaceuticals Inc. | 5d44daa9-d0e9-eec0-e063-6394a90a81e4 | 2026-10-07 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| bupropion | BUPROPION | Zydus Pharmaceuticals USA Inc. | 8d937ca3-3351-40f1-8192-348ba0c68162 | 2026-10-05 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| Artifical Tears | GLYCERIN AND PROPYLENE GLYCOL | Wal-Mart Stores Inc | 99cfea82-afb8-4c5f-ac0c-492204a42c08 | 2026-10-02 | Warnings | 6DC9Q167V3 |
| Bupropion hydrochloride | BUPROPION HYDROCHLORIDE | Proficient Rx LP | f1703bfd-be36-4fde-8e67-df0fb5d93369 | 2026-10-01 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| Bupropion hydrochloride | BUPROPION HYDROCHLORIDE | BluePoint Laboratories | 4956af38-182a-4015-a945-67e40bd38772 | 2026-09-30 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| Bupropion Hydrochloride SR | BUPROPION HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 5f8b3313-0286-499f-9235-02cdc0eb063b | 2026-09-29 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.